Patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were taking cholesterol-lowering ...

Statins appeared to reduce the risk for hepatocellular carcinoma and hepatic decompensation among patients with chronic liver ...

A new study found that adding a second drug early after a heart attack may save lives. Those who added ezetimibe to a statin ...

controlled trials suggests that reduction of low-density lipoprotein cholesterol with hydroxymethylglutaryl coenzyme A reductase inhibitor (statin) therapy in patients at high risk for ...

Though high cholesterol may contribute to the risk of developing Alzheimer’s disease or a related dementia (ADRD), taking a statin did not seem to protect people from the disease, a study finds. The ...

The trade-off would be five cases of myopathy (muscle weakness ... later corrected – that questioned use of statins in healthy people at low risk of heart disease. These articles were heavily ...

A recent review highlights the gaps in clinical guidelines and treatment approaches for metabolic dysfunction-associated ...

Cholesterol-lowering statin ... risk over 10 years of a cardiovascular event, such as a heart attack or stroke. The new guidance, however, suggests they could be an option for patients with lower ...

Use of statins conveyed an additional protective effect for people with low LDL-C, specifically those with blood levels less than 1.8 mmol/L (70 mg/dL), reducing their risk of dementia even further.

One study explored the use of statins, a class of medications typically used to lower LDL cholesterol levels to reduce the risk of stroke and heart disease. Researchers found that statin use ...